Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    22047557 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
Condition: Cystic Fibrosis
Interventions: Drug: Ivacaftor;   Drug: Placebo
2 Active, not recruiting Cystic Fibrosis Related Bone Disease: the Role of CFTR
Condition: Cystic Fibrosis Related Bone Disease
Intervention:
3 Recruiting Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention: Procedure: Nasal swab; rectal biopsy.

Study has passed its completion date and status has not been verified in more than two years.